KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

LifeMD (LFMD) Equity Average (2016 - 2025)

Historic Equity Average for LifeMD (LFMD) over the last 13 years, with Q3 2025 value amounting to $792799.0.

  • LifeMD's Equity Average rose 11704.27% to $792799.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $792799.0, marking a year-over-year increase of 11704.27%. This contributed to the annual value of -$2.4 million for FY2024, which is 3629.28% up from last year.
  • According to the latest figures from Q3 2025, LifeMD's Equity Average is $792799.0, which was up 11704.27% from -$2.1 million recorded in Q2 2025.
  • LifeMD's 5-year Equity Average high stood at $17.4 million for Q1 2022, and its period low was -$14.3 million during Q3 2023.
  • In the last 5 years, LifeMD's Equity Average had a median value of -$4.2 million in 2023 and averaged -$3.2 million.
  • As far as peak fluctuations go, LifeMD's Equity Average surged by 75561.2% in 2022, and later tumbled by 268552.61% in 2023.
  • Quarter analysis of 5 years shows LifeMD's Equity Average stood at $2.0 million in 2021, then plummeted by 424.38% to -$6.6 million in 2022, then skyrocketed by 35.93% to -$4.2 million in 2023, then plummeted by 67.18% to -$7.1 million in 2024, then surged by 111.18% to $792799.0 in 2025.
  • Its Equity Average stands at $792799.0 for Q3 2025, versus -$2.1 million for Q2 2025 and -$5.7 million for Q1 2025.